| UniProt ID | MSL2_HUMAN | |
|---|---|---|
| UniProt AC | Q9HCI7 | |
| Protein Name | E3 ubiquitin-protein ligase MSL2 | |
| Gene Name | MSL2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 577 | |
| Subcellular Localization | ||
| Protein Description | Component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at lysine 16 which is implicated in the formation of higher-order chromatin structure. Acts as an E3 ubiquitin ligase that promotes monoubiquitination of histone H2B at 'Lys-35' (H2BK34Ub), but not that of H2A. This activity is greatly enhanced by heterodimerization with MSL1. H2B ubiquitination in turn stimulates histine H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1.. | |
| Protein Sequence | MNPVNATALYISASRLVLNYDPGDPKAFTEINRLLPYFRQSLSCCVCGHLLQDPIAPTNSTCQHYVCKTCKGKKMMMKPSCSWCKDYEQFEENKQLSILVNCYKKLCEYITQTTLARDIIEAVDCSSDILALLNDGSLFCEETEKPSDSSFTLCLTHSPLPSTSEPTTDPQASLSPMSESTLSIAIGSSVINGLPTYNGLSIDRFGINIPSPEHSNTIDVCNTVDIKTEDLSDSLPPVCDTVATDLCSTGIDICSFSEDIKPGDSLLLSVEEVLRSLETVSNTEVCCPNLQPNLEATVSNGPFLQLSSQSLSHNVFMSTSPALHGLSCTAATPKIAKLNRKRSRSESDSEKVQPLPISTIIRGPTLGASAPVTVKRESKISLQPIATVPNGGTTPKISKTVLLSTKSMKKSHEHGSKKSHSKTKPGILKKDKAVKEKIPSHHFMPGSPTKTVYKKPQEKKGCKCGRATQNPSVLTCRGQRCPCYSNRKACLDCICRGCQNSYMANGEKKLEAFAVPEKALEQTRLTLGINVTSIAVRNASTSTSVINVTGSPVTTFLAASTHDDKSLDEAIDMRFDC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Phosphorylation | -MNPVNATALYISAS -CCCCCHHHEEEEHH | 16.40 | 23663014 | |
| 10 | Phosphorylation | PVNATALYISASRLV CCCHHHEEEEHHEEE | 7.14 | 23663014 | |
| 12 | Phosphorylation | NATALYISASRLVLN CHHHEEEEHHEEECC | 13.46 | 23663014 | |
| 14 | Phosphorylation | TALYISASRLVLNYD HHEEEEHHEEECCCC | 21.25 | 23663014 | |
| 20 | Ubiquitination | ASRLVLNYDPGDPKA HHEEECCCCCCCHHH | 21.25 | 29967540 | |
| 20 | Phosphorylation | ASRLVLNYDPGDPKA HHEEECCCCCCCHHH | 21.25 | 19605366 | |
| 26 | Ubiquitination | NYDPGDPKAFTEINR CCCCCCHHHHHHHHH | 61.95 | - | |
| 29 | Phosphorylation | PGDPKAFTEINRLLP CCCHHHHHHHHHHHH | 40.59 | - | |
| 78 | Acetylation | KGKKMMMKPSCSWCK CCCEEEECCCCHHCC | 18.84 | 26051181 | |
| 85 | Ubiquitination | KPSCSWCKDYEQFEE CCCCHHCCCHHHHHH | 58.02 | 29967540 | |
| 94 | Ubiquitination | YEQFEENKQLSILVN HHHHHHHHHHHHHHH | 56.76 | 29967540 | |
| 104 | Acetylation | SILVNCYKKLCEYIT HHHHHHHHHHHHHHH | 41.28 | 7692255 | |
| 105 | Ubiquitination | ILVNCYKKLCEYITQ HHHHHHHHHHHHHHH | 31.71 | - | |
| 109 | Phosphorylation | CYKKLCEYITQTTLA HHHHHHHHHHHHHHH | 14.31 | 24719451 | |
| 113 | Phosphorylation | LCEYITQTTLARDII HHHHHHHHHHHHHHH | 18.35 | 24719451 | |
| 114 | Phosphorylation | CEYITQTTLARDIIE HHHHHHHHHHHHHHH | 14.49 | - | |
| 137 | Phosphorylation | LALLNDGSLFCEETE HHHHCCCCCEEEECC | 22.57 | 32142685 | |
| 149 | Phosphorylation | ETEKPSDSSFTLCLT ECCCCCCCCEEEEEE | 31.52 | 26074081 | |
| 150 | Phosphorylation | TEKPSDSSFTLCLTH CCCCCCCCEEEEEEC | 27.52 | 26074081 | |
| 152 | Phosphorylation | KPSDSSFTLCLTHSP CCCCCCEEEEEECCC | 20.64 | 26074081 | |
| 156 | Phosphorylation | SSFTLCLTHSPLPST CCEEEEEECCCCCCC | 21.22 | 26074081 | |
| 158 | Phosphorylation | FTLCLTHSPLPSTSE EEEEEECCCCCCCCC | 23.93 | 26074081 | |
| 162 | Phosphorylation | LTHSPLPSTSEPTTD EECCCCCCCCCCCCC | 52.85 | 26074081 | |
| 163 | Phosphorylation | THSPLPSTSEPTTDP ECCCCCCCCCCCCCC | 34.86 | 26074081 | |
| 164 | Phosphorylation | HSPLPSTSEPTTDPQ CCCCCCCCCCCCCCC | 46.01 | 26074081 | |
| 211 | Phosphorylation | RFGINIPSPEHSNTI CCCCCCCCCCCCCCC | 38.84 | 30266825 | |
| 215 | Phosphorylation | NIPSPEHSNTIDVCN CCCCCCCCCCCEECC | 33.72 | 30266825 | |
| 217 | Phosphorylation | PSPEHSNTIDVCNTV CCCCCCCCCEECCCE | 22.90 | 30266825 | |
| 223 | Phosphorylation | NTIDVCNTVDIKTED CCCEECCCEECCHHH | 17.90 | 28450419 | |
| 228 | Phosphorylation | CNTVDIKTEDLSDSL CCCEECCHHHHHCCC | 34.76 | 28270605 | |
| 261 | Ubiquitination | CSFSEDIKPGDSLLL ECCCCCCCCCCEEEE | 56.10 | - | |
| 277 | Ubiquitination | VEEVLRSLETVSNTE HHHHHHHCCCCCCCE | 5.31 | 29967540 | |
| 301 | Ubiquitination | LEATVSNGPFLQLSS CEEEECCCCCEEEEC | 13.56 | 29967540 | |
| 325 | Ubiquitination | STSPALHGLSCTAAT CCCHHHHCCCCCCCC | 21.82 | 29967540 | |
| 335 | Ubiquitination | CTAATPKIAKLNRKR CCCCCHHHHHHHHHC | 4.26 | 30230243 | |
| 343 | Phosphorylation | AKLNRKRSRSESDSE HHHHHHCCCCCCCCC | 43.10 | 23401153 | |
| 345 | Phosphorylation | LNRKRSRSESDSEKV HHHHCCCCCCCCCCC | 42.57 | 30266825 | |
| 347 | Phosphorylation | RKRSRSESDSEKVQP HHCCCCCCCCCCCCC | 47.92 | 30266825 | |
| 349 | Phosphorylation | RSRSESDSEKVQPLP CCCCCCCCCCCCCCC | 48.90 | 30266825 | |
| 351 | Ubiquitination | RSESDSEKVQPLPIS CCCCCCCCCCCCCCE | 50.55 | 29967540 | |
| 358 | Phosphorylation | KVQPLPISTIIRGPT CCCCCCCEEEEECCC | 16.18 | 23927012 | |
| 359 | Phosphorylation | VQPLPISTIIRGPTL CCCCCCEEEEECCCC | 22.57 | 23927012 | |
| 363 | Ubiquitination | PISTIIRGPTLGASA CCEEEEECCCCCCCC | 14.77 | 29967540 | |
| 365 | Phosphorylation | STIIRGPTLGASAPV EEEEECCCCCCCCCE | 40.42 | 23312004 | |
| 369 | Phosphorylation | RGPTLGASAPVTVKR ECCCCCCCCCEEEEC | 31.16 | 25159151 | |
| 373 | Phosphorylation | LGASAPVTVKRESKI CCCCCCEEEECCCCC | 21.17 | 32142685 | |
| 375 | Ubiquitination | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | 29967540 | |
| 375 | Acetylation | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | 25953088 | |
| 375 | Sumoylation | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | 28112733 | |
| 375 | Sumoylation | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | - | |
| 376 | Ubiquitination | SAPVTVKRESKISLQ CCCEEEECCCCCCEE | 49.43 | 29967540 | |
| 379 | Ubiquitination | VTVKRESKISLQPIA EEEECCCCCCEEEEE | 31.40 | - | |
| 380 | Ubiquitination | TVKRESKISLQPIAT EEECCCCCCEEEEEE | 7.47 | 29967540 | |
| 387 | Phosphorylation | ISLQPIATVPNGGTT CCEEEEEECCCCCCC | 36.90 | 28122231 | |
| 393 | Phosphorylation | ATVPNGGTTPKISKT EECCCCCCCCCCCEE | 41.12 | 25159151 | |
| 394 | Phosphorylation | TVPNGGTTPKISKTV ECCCCCCCCCCCEEE | 26.34 | 25159151 | |
| 399 | Ubiquitination | GTTPKISKTVLLSTK CCCCCCCEEEEECCC | 46.24 | 29967540 | |
| 400 | Phosphorylation | TTPKISKTVLLSTKS CCCCCCEEEEECCCC | 15.03 | - | |
| 404 | Phosphorylation | ISKTVLLSTKSMKKS CCEEEEECCCCCHHH | 29.63 | 24719451 | |
| 406 | Acetylation | KTVLLSTKSMKKSHE EEEEECCCCCHHHHC | 45.22 | 25953088 | |
| 406 | Ubiquitination | KTVLLSTKSMKKSHE EEEEECCCCCHHHHC | 45.22 | - | |
| 409 | Ubiquitination | LLSTKSMKKSHEHGS EECCCCCHHHHCCCC | 59.21 | 30230243 | |
| 419 | Phosphorylation | HEHGSKKSHSKTKPG HCCCCCCCCCCCCCC | 36.41 | - | |
| 421 | Phosphorylation | HGSKKSHSKTKPGIL CCCCCCCCCCCCCCC | 49.46 | - | |
| 435 | Ubiquitination | LKKDKAVKEKIPSHH CCCCHHHHHHCCCCC | 59.14 | 29967540 | |
| 437 | Ubiquitination | KDKAVKEKIPSHHFM CCHHHHHHCCCCCCC | 54.95 | 29967540 | |
| 440 | Phosphorylation | AVKEKIPSHHFMPGS HHHHHCCCCCCCCCC | 32.82 | 29255136 | |
| 447 | Phosphorylation | SHHFMPGSPTKTVYK CCCCCCCCCCCCEEC | 24.43 | 23401153 | |
| 449 | Phosphorylation | HFMPGSPTKTVYKKP CCCCCCCCCCEECCC | 40.83 | 29255136 | |
| 450 | Ubiquitination | FMPGSPTKTVYKKPQ CCCCCCCCCEECCCC | 39.10 | 29967540 | |
| 453 | Phosphorylation | GSPTKTVYKKPQEKK CCCCCCEECCCCCCC | 20.65 | 17053785 | |
| 454 | Ubiquitination | SPTKTVYKKPQEKKG CCCCCEECCCCCCCC | 54.35 | 29967540 | |
| 488 | Ubiquitination | CPCYSNRKACLDCIC CCCCCCCCHHHHHHH | 47.94 | - | |
| 501 | Phosphorylation | ICRGCQNSYMANGEK HHHCCCCCHHCCCCH | 7.15 | 29978859 | |
| 502 | Phosphorylation | CRGCQNSYMANGEKK HHCCCCCHHCCCCHH | 14.06 | 29978859 | |
| 508 | Acetylation | SYMANGEKKLEAFAV CHHCCCCHHEEEEEC | 65.15 | 26051181 | |
| 508 | Ubiquitination | SYMANGEKKLEAFAV CHHCCCCHHEEEEEC | 65.15 | - | |
| 509 | Ubiquitination | YMANGEKKLEAFAVP HHCCCCHHEEEEECC | 47.46 | 29967540 | |
| 509 | Acetylation | YMANGEKKLEAFAVP HHCCCCHHEEEEECC | 47.46 | 26051181 | |
| 518 | Ubiquitination | EAFAVPEKALEQTRL EEEECCHHHHHHHHE | 52.80 | - | |
| 518 | Acetylation | EAFAVPEKALEQTRL EEEECCHHHHHHHHE | 52.80 | 25953088 | |
| 540 | Phosphorylation | SIAVRNASTSTSVIN EEEEEECCCCCEEEE | 26.83 | 30108239 | |
| 541 | Phosphorylation | IAVRNASTSTSVINV EEEEECCCCCEEEEC | 33.35 | 27251275 | |
| 542 | Phosphorylation | AVRNASTSTSVINVT EEEECCCCCEEEECC | 19.05 | 27251275 | |
| 543 | Phosphorylation | VRNASTSTSVINVTG EEECCCCCEEEECCC | 27.40 | 27251275 | |
| 544 | Phosphorylation | RNASTSTSVINVTGS EECCCCCEEEECCCC | 22.29 | 30108239 | |
| 549 | Phosphorylation | STSVINVTGSPVTTF CCEEEECCCCCCCEE | 27.70 | 28450419 | |
| 551 | Phosphorylation | SVINVTGSPVTTFLA EEEECCCCCCCEEEE | 13.56 | 28450419 | |
| 554 | Phosphorylation | NVTGSPVTTFLAAST ECCCCCCCEEEECCC | 18.40 | 28450419 | |
| 555 | Phosphorylation | VTGSPVTTFLAASTH CCCCCCCEEEECCCC | 19.52 | 28450419 | |
| 560 | Phosphorylation | VTTFLAASTHDDKSL CCEEEECCCCCCCCH | 22.22 | 22199227 | |
| 561 | Phosphorylation | TTFLAASTHDDKSLD CEEEECCCCCCCCHH | 25.29 | - | |
| 566 | Phosphorylation | ASTHDDKSLDEAIDM CCCCCCCCHHHHHHH | 48.31 | 25849741 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MSL2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MSL2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MSL2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| P53_HUMAN | TP53 | physical | 19033443 | |
| H2A2C_HUMAN | HIST2H2AC | physical | 21726816 | |
| H2A2A_HUMAN | HIST2H2AA3 | physical | 21726816 | |
| H2B2E_HUMAN | HIST2H2BE | physical | 21726816 | |
| H32_HUMAN | HIST2H3C | physical | 21726816 | |
| UB2D3_HUMAN | UBE2D3 | physical | 21726816 | |
| TRIM8_HUMAN | TRIM8 | physical | 22493164 | |
| H2B2E_HUMAN | HIST2H2BE | physical | 24837678 | |
| UB2D3_HUMAN | UBE2D3 | physical | 24837678 | |
| BRE1A_HUMAN | RNF20 | physical | 24837678 | |
| BRE1B_HUMAN | RNF40 | physical | 24837678 | |
| PAF1_HUMAN | PAF1 | physical | 24837678 | |
| CDK9_HUMAN | CDK9 | physical | 24837678 | |
| MSL1_HUMAN | MSL1 | physical | 28514442 | |
| KAT8_HUMAN | KAT8 | physical | 28514442 | |
| MS3L1_HUMAN | MSL3 | physical | 28514442 | |
| HBB_HUMAN | HBB | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-453, AND MASSSPECTROMETRY. | |